RSP News 76.10 06/09/2014 05:24:32 S&P 500 Index Equal Weight

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
S&P 500 Index Equal Weight Guggenheim (RSP) 76.10 $RSP

Noteworthy ETF Inflows: RSP, POM, AGN, SNDK
ETFChannel.com - Mon May 19, 10:02AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Guggenheim S&P 500 Equal Weight ETF where we have detected an approximate $157.3 million dollar inflow -- that's a...

After Yesterday's Rally of 1.12% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon May 12, 5:24PM CDT
Rydex S&P Equal Weight ETF (AMEX:RSP) traded in a range yesterday that spanned from a low of $73.45 to a high of $74.02. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $73.72 on volume of 2.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Knowing ETF Firms' Traits Can Help You Sort Field
at Investor's Business Daily - Thu Apr 17, 5:15PM CDT
In the world of ETFs, there are large ETF issuers and there are tiny ones. Aside from looking at the asset size and the availability of a particular ETF that fits an investor's strategy, one needs to consider other differentiating factors among ETF...

An ETF Strategy for a Volatile Second Quarter
at The Street - Mon Mar 24, 10:28AM CDT
Selecting the right exchange-traded funds will help the investor play defense in this environment.

Investment Strategies 2014: How to Invest in Any Market
Jason Hall, The Motley Fool - Motley Fool - Sun Jan 12, 9:04AM CST
For investors, 2013 was one of the best years in recent memory. The S&P 500 climbed 29.6%, its best year since 1997, while the Dow Jones Industrial Average climbed just under 30% for its largest one-year jump since 1995.  Even the Nasdaq ...

Is 'Smart Beta' Just a Fancy Word Trick?
Ron DeLegge - ETFG - Fri Dec 06, 12:06AM CST
Smart beta strategies are being touted as a new dynamic and better way to invest in securities. But are they just small cap and value investing posing as something else?

This Tweaked Index Fund Has Been Trouncing the S&P 500
Selena Maranjian, The Motley Fool - Motley Fool - Mon Aug 12, 8:38PM CDT
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some large-cap stocks to your portfolio but don't have the time or expertise to hand-pick a few, the Guggenheim S&P 500 Equal...

VelocityShares Launches Equal Risk Weighted ETF - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Thu Aug 01, 9:15AM CDT
For an equal risk approach to large caps, take a look at this new fund from VelocityShares (ERW).

Overweight These Equal Weight ETFs in Your Portfolio - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Jul 29, 10:30AM CDT
Why investors might want to consider equal weight ETFs.

I Bet You're Probably Losing: Try Something That Actually Works
Blogs @ The Motley Fool - Motley Fool - Thu Jul 11, 2:50PM CDT
I read two articles today, that were both stark reminders that most of us are really bad at investing. From Foolish contributor Morgan Housel: Most investors underperform the market. When that's the case, how to become a...

An Easy Way to Beat the S&P 500
Blogs @ The Motley Fool - Motley Fool - Tue Jun 25, 1:10PM CDT
Beating the market isn't easy, but one very simple strategy outperforms year after year. It has nothing to do with market timing or leverage, nor do investors need to actively hunt down stocks. Most funds are market-cap weighted, so...

SmarTrend Watching for Potential Rebound in Shares of Rydex S&P Equal Weight ETF After 1.46% Loss
Comtex SmarTrend(R) - Wed Jun 05, 4:42PM CDT
Rydex S&P Equal Weight ETF (AMEX:RSP) traded in a range yesterday that spanned from a low of $61.13 to a high of $62.01. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $61.74 on volume of 3.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Rydex S&P Equal Weight ETF Has Returned 20.7% Since SmarTrend Recommendation (RSP)
Comtex SmarTrend(R) - Fri May 31, 11:05AM CDT
SmarTrend identified an Uptrend for Rydex S&P Equal Weight ETF (AMEX:RSP) on November 29th, 2012 at $52.31. In approximately 6 months, Rydex S&P Equal Weight ETF has returned 20.73% as of today's recent price of $63.15.

Rydex S&P Equal Weight ETF Up 19.9% Since SmarTrend Uptrend Call (RSP)
Comtex SmarTrend(R) - Fri May 24, 9:57AM CDT
SmarTrend identified an Uptrend for Rydex S&P Equal Weight ETF (AMEX:RSP) on November 29th, 2012 at $52.31. In approximately 6 months, Rydex S&P Equal Weight ETF has returned 19.87% as of today's recent price of $62.70.

10 Year Report: Equal Weight Strategy Beats S&P 500
Ron DeLegge - ETFG - Thu Apr 25, 11:24PM CDT
Should investors start switching away from traditional market cap indexes?

Are Equal Weight ETFs Worth The Cost? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Mar 20, 8:00AM CDT
Should investors pay a bit more for equal weighting, or is market capitalization the way to go?

S&P 500 ETFs: Comparing The “Twisted” Funds
Stoyan Bojinov - ETFDB - Thu Feb 28, 3:00AM CST
It’s pretty darn hard, if not altogether impossible, to read through any sort of financial publication these days without running across some mention of the S&P 500 Index. This revered benchmark has found its way onto the radar screens of...

Schwab Ups the Ante with Commission-Free ETF Platform
etf@etfguide.com - ETFG - Thu Feb 07, 11:29PM CST
Schwab will now include 105 ETFs from various families on its list of funds eligible for commission free trading.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 80

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 242

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 559

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 74

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 25

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Alert: LifeMD Inc Faces Legal Investigation Risks

Updated Category News Views 167

Understanding Recent Developments for LifeMD, Inc. LifeMD, Inc. (NASDAQ: LFMD) is presently facing serious legal scrutiny following an investigation initiated by Faruqi & Faruqi, LLP. This renowned national securities law firm has stepped in to evaluate potential claims on behalf of investors. Investor Engagement Opportunities If you are among the investors who incurred...

Continue Reading
Value Stocks Poised for Growth Amid Market Shifts

Updated Category News Views 119

Value Stocks Set for Growth as Market Dynamics Change The stock market is currently experiencing a notable shift away from tech dominance. In recent months, tech stocks have faced challenges, raising questions about the potential revival of value stocks. This change in market sentiment is particularly evident in the impressive performance of the Value ETF, which has...

Continue Reading
EXEL Industries Reveals Key Share and Voting Rights Insights

Updated Category News Views 57

EXEL Industries Overview EXEL Industries is a prominent French Société Anonyme, with a robust share capital amounting to €16,969,750. The company has established a significant presence in the industry through its high standards and innovative products. Understanding Share Capital and Voting Rights On August 31, 2024, EXEL Industries provided updated insights regarding...

Continue Reading
Protective Life Corporation Strengthens Portfolio with Acquisition

Updated Category News Views 112

Protective Life Corporation Strengthens Its Portfolio In a significant development for Protective Life Corporation, the company has successfully completed the acquisition of ShelterPoint Group, Inc. Shielded under the corporate umbrella of Dai-ichi Life Holdings, Inc., Protective Life Corporation continues to solidify its position in the employee benefits industry. This...

Continue Reading
Safeguarding Your Personal Data in a Digital Health Era

Updated Category News Views 160

Understanding the Importance of Data Security in Health Tech As the holiday season approaches, consumers are excitedly purchasing various digital health tools such as fitness trackers, meditation apps, and smart scales. While these innovations can greatly enhance our wellness journey, they also raise significant concerns regarding the security of our personal data. Expert...

Continue Reading